Sommadossi Jean-Pierre 4
4 · Atea Pharmaceuticals, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Sommadossi Jean-Pierre
DirectorPresident, CEO, and Chairman
Transactions
- Sale
Common Stock
2024-06-05$4.00/sh−1,006$4,024→ 5,923,994 total(indirect: By LLC)
Holdings
- 116,557
Common Stock